19 results on '"Bortesi B"'
Search Results
2. 145P High-risk breast cancer patients with RAD51-low tumors are characterized by good prognosis
3. Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
4. Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
5. Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy
6. Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy
7. Brca Status, Molecular Profile and Clinical Variables in Primary Bilateral Breast Cancers: A Population-Based Cancer Registry Study
8. KRAS mutations in colorectal cancer patients in Italy: Results from the KRAS aKtive program.
9. EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations
10. 522 POSTER Immunoglobulin G fragment C receptor polymorphisms and clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with cetuximab-based therapy
11. Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer
12. BRCA1 status, molecular markers, clinical variables in breast cancer patients with high probability of having an inherited genetic mutation
13. Male breast cancer in Parma Province: Descriptive epidemiology, molecular markers and clinical variables
14. Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC)
15. BRCA1 status, molecular markers, clinical variables in breast cancer patients with high probability of having an inherited genetic mutation
16. Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC)
17. Male breast cancer in Parma Province: Descriptive epidemiology, molecular markers and clinical variables
18. Loss of heterozygosity (LOH) in ovarian cancer
19. P2 BRCA-1 status, molecular markers, and clinical variables in breast cancer patients with high probability of having an inherited, cancer-predisposing genetic mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.